Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM

Clinical trial NCT01912534 · COMPLETED

Trial details

NCT number: NCT01912534
Sponsor: Carelon Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertrophic Cardiomyopathy

Start date: 2014-03-01
Primary completion: 2019-07-01
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.